Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus
AIM: To analyze the prognostic value of the polymorphisms of the thrombophilic genes: plasminogen activator inhibitor type 1 (PAI-1) (–675 4G/5G), factor XIII (FXIII) (G485T), fibrinogen (FBG) (G(–455)A), glycoprotein Ia (GPIa) (C807T), glycoprotein IIIa (GPIIIa) (T106C), and p22phox (C242T), as wel...
Main Authors: | E N Borisov, T N Krasnova, L M Samokhodskaia, L V Ivanitskiĭ, N V Nikiforova, N A Mukhin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-06-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31504 |
Similar Items
-
STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01) -
PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01) -
NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01) -
Anaesthetic implications of antiphospholipid antibody syndrome in pregnancy
by: Priyanka Garg, et al.
Published: (2011-01-01) -
Experience with outpatient treatment for thromboses and thrombophilias
by: S A Vasil'ev, et al.
Published: (2013-12-01)